改善20CrMnTiH淬透性的研究

莱钢特钢厂20CrMnTiH钢材成分波动较大,淬透性带HRC8～10,范围较大,制约了齿轮钢质量的进一步提高.通过研究,发现铸坯中心偏析尤其是碳偏析为主要问题.通过工艺优化采取各项措施,尤其增加电磁搅拌后,中心碳偏析得到明显改善;C控制在0.19%～0.20%的炉次达到了95.6%;淬透性带控制在HRC6内的达到了92.1%;在HRC4内的达到了86.2%;提高了产品质量,满足了用户需求.     

Zur Entstehung des Lungenödems

Ohne Zusammenfassung     

GFMIMU/GPS组合导航系统信息融合技术研究

GFMIMU/GPS(Gyroscope Free Micro Inertial Measurement Unit/Global Positioning System)组合导航系统具有抗高g值冲击、低成本、长寿命、较高精度等优点,在低成本精确制导武器和微小型无人机具有广阔的应用前景。针对工程应用中信息融合的精度和实时性两方面的要求,运用基于模型误差预测的扩展卡尔曼滤波MEP-EKF(Extended Kalman Filter base on Model Error Predictive)方法,将MEMS(Micro Electromechanical Systems)加速度计的误差作为模型误差来考虑,对GFMIMU/GPS组合导航系统进行建模仿真,将其与EKF和UKF(Unscented Kalman Filter)方法进行了仿真比较,在方位误差角的估计上取得了比他们精度高的仿真结果,而且MEP-EKF所需时间是UKF的10%.     

反渗透系统的设计思路探讨

反渗透作为一种重要的水处理技术,越来越广泛地应用到各种领域,其处理水源也变得复杂多样化,因此要求在反渗透系统和反渗透预处理设计时予以高度关注。本文主要讨论针对不同水源时反渗透系统的设计思路。     

Therapeutic applications of bone marrow-derived stem cells in liver transplantation for end-stage liver diseases

Today, liver transplantation (LT) is the only established treatment for end-stage liver diseases. The de- velopment of LT, including OLT, cadaveric LT, split LT, living donor LT (LDLT), brings hopes to patients with these diseases. However, increasing donor shortage, rejection and life-long immunosuppression with its side effects are the major limitations of this therapy strategy. Bone marrow-derived stem cells (BMDSCs) are capable of differentiating into hepatocyte-like cells and contribute to liver injury repair. The microenvironment of liver injury caused by rejection, ischemia/reperfusion, loss of liver mass, recurrence of HCV and "small-for-size syndrome" after LT can attract a variety of bone marrow-derived stem cell population to the peripheral circulation and then migration to the injury liver to promote the hepatic function restoration. Additionally, BMDSCs can also take part in the functional regeneration of living donor liver after LDLT. This participation in liver regeneration may be associated to the interac- tion between SDF-1and its receptor CXCR4, involving HGF, IL-8, MMP9, and VEGF/VEGFR-2. BMDSC with its bio-characteristics could maintain the allograft tolerance from different angles and in different ways. In conclusion, BMDSCs transplantation, as a new assistant therapeutic method for LT, will ex- pand the space of LT, and provide more survival opportunities for the patients suffering liver diseases in the future.